Anteo Diagnostics Ltd has released a press release.
Rights Commence Trading
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- Rights Issue Prospectus
- AnteoTech Granted Key US Battery Patent
- Response to ASXs Price Query
- Battery Program Update
- IMRA Contract Additional Information
Later from AnteoTech
- Heads of Agreement signed with Merck
- Rights Issue Raises $2.15 million
- R & D Refund Received
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
- AnteoTech Advances Battery Technology Program
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech